Interferon-induced Parkinsonism in a patient with chronic hepatitis C

Arquivos de Neuro-Psiquiatria

Volumn 67, Issue 3 A, 2009, Pages 715-716

  De Almeida, Carlos Mauricio Oliveira ^a,b   Galvão, Maria De Lourdes De Souza ^a   Ferreira, Paulo Luis Da Costa ^a   Braga, Wornei Silva ^a  

^a FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; PEGINTERFERON ALPHA2A; PROPRANOLOL; RIBAVIRIN;

AGED; ARM; ARTICLE; BLOOD TRANSFUSION; BODY POSTURE; BRAIN; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; REST; RIGIDITY; SCORING SYSTEM; TREATMENT DURATION; TREMOR;

EID: 69749119799     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2009000400031     Document Type: Article

References (20)

1. Organização Mundial de Saúde. Hepatite C. Disponível em: 〈http://www.who.int/docstore/wer/pdf/1999/wer7449. pdf/〉 Acesso em: 18 setembro. 2008.
2. Choo Qui-Lim, Amy GK ,Weiner AJ, Overby LC, Bradley DW, Houghton M. Isolation of c-DNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-361. (Pubitemid 19117877)
3. Bukh J,Purcell RH, Miller RH. Sequence analysis of the 5′noncoding region of hepatitis C virus. Proc Natl Acad Sci 1992;89:4942-4946.
4. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci 1990;87:9524-9528. (Pubitemid 120016475)
5. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:. 2391-2399. (Pubitemid 23332300)
6. Simmonds P, Bukh J, Combet C, et al. A Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973. (Pubitemid 41401136)
7. de Araújo ES, Mendonça JS, Barone AA, et al. Consensus of the Brazilian Society of Infectious Diseases on the management and treatment of hepatitis C. Braz J Infect Dis 2007;11:446-450.
8. Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 2006;55:1350-1359. (Pubitemid 44277369)
9. Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991:41:672-676.
10. Moulignier A, Allo S, Zittoun R, Gout O. Recombinant interferon-a-induced chorea and frontal subcortical dememntia. Neurology 2002;58:328-330. (Pubitemid 34084236)
11. Tan Eng-King, Chan Ling-Ling, Lo Yew-Long. Myorhythmia slow facial tremor from chronic interferon alpha-2a usage. Neurology 2003:61:1302-1303.
12. Mizoi Y, Kaneko H, Oharazawa A, Kuroiwa H. Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C. Rinsho Shinkeigaku 1997;37:54-56.
13. Wada Y, Kuwahara T, Uyama E, et al. Neurologic toxicity associated with interferon: a therapy for renal cell carcinoma. Internat J Urol 2006;13:811-813. (Pubitemid 43926780)
14. Couto CM, Ribas FD, Fonseca PG, et al. Interferon-alfa como causa de parkinsonismo: relato de Caso. Arq Neuropsiquiatr 2008;66(Suppl 2): 238.
15. Bersano A, Aghemo A, Rumi MG, Ballabio E, Candelise L, Colombo M. Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism. Eur J Inter Med 2008;19:370-371. (Pubitemid 351790762)
16. a Ed. Rio de Janeiro: Elsevier, 2005: 251-282.
17. Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R. Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 1997;747:348-351. (Pubitemid 27077413)
18. Di Bisceglie AM, Shindo M, Fong TL, et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992;16:649-654.
19. Urganci N, Gulec SG, Arapoglu M, Vural S, Nuhog A. the effect of ribavirin on bone density in patients with chronic hepatitis C treated with interferon-ribavirin therapy. J Pediatr Gastroenterol Nutr 2005;41:650-652. (Pubitemid 41579678)
20. Martin P, Jensen DM. Ribavirin in the treatment of chronic hepatitis C. Hepatology 2008;23:844-855.